---
schema_version: '1.0'
id: news-20260727-fbbf9b
url: https://www.nikkei.com/article/DGXZQOFL270DK0X20C26A7000000/
url_hash: fbbf9bbc0f683236557700546295caa832a12345d0e4217ba0376d616eab52ac
canonical_url: https://www.nikkei.com/article/DGXZQOFL270DK0X20C26A7000000
source: bing
category: news/business
category_raw: business
region: JP
tags:
- business
- 日本経済新聞
lang: ja
published_at: '2026-07-26T13:01:00Z'
fetched_at: '2026-07-27T01:07:23.050689Z'
updated_at: '2026-07-27T01:07:28Z'
status: published
content_hash: null
content_changed_at: null
license_note: link-only
summary: null
summary_source: null
summary_en: null
entities:
- name: Business Insider
  type: organization
- name: 日本経済新聞
  type: organization
key_facts: []
related: []
related_auto:
- name: shinbun-renki
  type: organization
  weight: 3.0
- name: BING
  type: organization
  weight: 2.0
- name: TikTok
  type: organization
  weight: 1.0
- name: 投稿者
  type: person
  weight: 1.0
- name: サイオステクノロジー
  type: organization
  weight: 1.0
title: 中外製薬株価8カ月ぶり安値 1〜6月期純利益19%増も材料出尽くし
---

# 中外製薬株価8カ月ぶり安値 1〜6月期純利益19%増も材料出尽くし

## TL;DR
（要約なし・原文はリンク先を参照 / No summary available; see the source link.）

## Key Points
- business / 日本経済新聞

## Details
(本文なし。リンク先参照)

## Source
元記事: [中外製薬株価8カ月ぶり安値 1〜6月期純利益19%増も材料出尽くし](https://www.nikkei.com/article/DGXZQOFL270DK0X20C26A7000000/) — published 2026-07-26T13:01:00Z
